Targeting successful drug discovery and development requires targeted spending
Where pharmaceutical and life sciences companies spend their R&D dollars can be a critical factor in their ability to change and improve lives. The right data, tools and collaborations are vital to making the best decisions, successfully getting a drug to market, and ensuring patient safety.
Elsevier R&D Solutions help companies in the pharmaceutical and life sciences industries make better discovery and development decisions.
Elsevier R&D Solutions enables smarter early-stage
investment decisions to improve development of new
drugs and therapies with tools and solutions that help
researchers in the pharmaceutical and life sciences
industries better understand disease biology.
Elsevier R&D Solutions provides unique access to
DA and EMA drug-approval documents and data,
and biomedical literature that improves critical
decision-making in drug candidate selection
processes, study design and late-stage risk
management and mitigation.
Real Stories. Real Science. Real Time.
Meet the biotech companies selected to take part in The Hive - Elsevier's new program for startups that provides complimentary access to Elsevier’s suite of solutions to power their R&D. Follow The Hive for first-person stories from the fresh, innovative, and agile world of drug discovery and development and see how these companies are changing the industry’s landscape and improving the lives of patients.
Addressing Bottlenecks and Attrition Rates in Drug Development
High-quality data and in silico tools have considerable potential across the whole drug development process, if applied innovatively.
Pharmaceutical R&D Today
Read and comment on opinions by industry thought leaders on trending topics, including the use of big data in drug discovery and development, regulatory matters, medicinal chemistry, data management, and much more.
Advance your drug discovery and development capabilities
with Elsevier R&D Solutions
Reaxys improves productivity, combining experimental chemical data and essential literature to return relevant extracted chemical data and citations in response to chemistry questions.
Reaxys Medicinal Chemistry
Reaxys Medicinal Chemistry enables pharma researchers to quickly and confidently identify the most promising compounds, covering critical areas for medicinal chemistry research, including in vivo animal studies, in vitro efficacy, and drug pharmacokinetics and toxicity data.
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global research community.
PharmaPendium provides the comparative and up-to-date information needed to verify pharmacokinetic and experimental data, anticipate species-specific issues in translating in vitro and in vivo studies, and predict potential drug–drug interactions, and design clinical trial studies to comply with regulatory requirements.
QUOSA reduces time spent monitoring, managing, organizing and annotating scientific and medical literature for triage and compliance reports such as PSURs and ICSRs.
Pathway Studio facilitates the interpretation of experimental data, giving greater insight into the mechanisms of disease and accelerating biological research.
Elsevier R&D Solutions Professional Services team helps drive pharmaceutical research in innovative directions by resolving challenges with data quality and integration, resulting in data that is easier to manage, compare, analyze, interpret and share.
Elsevier’s customized Text Mining service provides meaningful answers to complex questions through the retrieval of highly specified information from unstructured content.
ScienceDirect, Elsevier’s leading information solution for researchers, enables pharmaceutical and life sciences researchers to more effectively and efficiently search authoritative, full-text scientific, technical and health content through the use of smart, intuitive functionality.
Scopus helps pharmaceutical and life sciences researchers detect trends, find research partnerships and identify key opinion leaders with the world’s largest abstract and citation database of peer-reviewed literature, complete with tools to track, analyze and visualize scholarly research.